Traws Pharma, Inc. business relationships

Companies named in Traws Pharma, Inc.’s 10-K filed 2026-04-15, and public companies whose annual reports name Traws Pharma, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.2 / 10
AI naming: <1 / 100
Agent readiness: 25 / 100
AI adoption: 0 / 100

Named in Traws Pharma, Inc.’s annual report 5

Merck & Co., Inc. (MRK)Sales channel7.7
“The FDA has authorized emergency use ("EUA") of oral molnupiravir (sold by Merck and Ridgeback).” SEC filing
Knight Therapeutics, Inc.Licensor4.7
“In November 2019, we entered into a Distribution, License and Supply Agreement (the "Knight License Agreement") with Knight Therapeutics Inc. ("Knight").” SEC filing
Knight Therapeutics, Inc.Supplier4.7
“Distribution, License and Supply Agreement, effective as of November 20, 2019, by and between Onconova Therapeutics, Inc. and Knight Therapeutics, Inc. ( Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on November 21, 2019 ).” SEC filing
Viriom, Inc.Licensor4.2
“License Agreement with Viriom, Inc. regarding Influenza Asset” SEC filing
Viriom, Inc.Supplier4.2
“The Company's patent, purchased in connection with the Purchased Assets from Viriom, Inc. ("Viriom") (Note 3), has a useful life of 15 years .” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.